close search

Professor Mark Hogarth

Head, Immune Therapies Group
Current Projects
Holding Image
Stellabody® PROJECT
Anti-COVID-19 biological drugs for prevention and treatment PROJECT
Fc receptor targeted treatments in inflammation and allergy PROJECT
Stellabody® technology in cancer therapy PROJECT
Holding Image
Harnessing Natural Killer cells to eliminate HIV PROJECT
Stellabody® technology in infectious disease – COVID-19 and beyond PROJECT